• Hydroxytyrosol: Optimizing Antioxidant Assays for Kidney & H

  2026-08-06

  Hydroxytyrosol, a potent 4-(2-hydroxyethyl)benzene-1,2-diol, unlocks precision in oxidative stress and cardiovascular health research. This guide delivers actionable workflows, troubleshooting insights, and data-driven protocol parameters to maximize reproducibility and translational relevance with APExBIO’s high-purity Hydroxytyrosol.

• Fulvestrant (ICI 182,780): Mechanism, Benchmarks & Protocols

  2026-08-06

  Fulvestrant (ICI 182,780) is a potent estrogen receptor (ER) antagonist distinguished by high affinity and specific ERα degradation, driving apoptosis induction in breast cancer cells. This article details its molecular mechanism, quantitative efficacy benchmarks, and practical protocol integration for research and clinical applications.

• Strategic Use of nor-Binaltorphimine in Opioid Circuit Resea

  2026-08-05

  This thought-leadership article explores how nor-Binaltorphimine dihydrochloride advances the mechanistic dissection of κ-opioid receptor pathways, with strategic insights for translational pain and addiction research. Drawing on recent circuit-level discoveries and practical workflow guidance, the discussion bridges experimental design with clinical context, empowering researchers to address the complexity of opioid signaling using best-in-class tools from APExBIO.

• SB203580: Optimizing p38 MAPK Signaling Pathway Research Wor

  2026-08-05

  SB203580, a selective p38 MAPK inhibitor, empowers researchers to dissect cellular stress and inflammation pathways with precision. This guide spotlights experimental enhancements, troubleshooting tactics, and cross-domain insights from recent regenerative medicine breakthroughs, enabling robust, reproducible results using APExBIO's high-purity reagent.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-08-04

  This study identifies Merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 3-chymotrypsin-like protease (3CLpro). The findings provide valuable mechanistic insight into protease inhibition and suggest Merbromin as a promising scaffold for antiviral drug development.

• EPZ-6438: EZH2 Inhibitor Protocols for Epigenetic Cancer Mod

  2026-08-04

  EPZ-6438 from APExBIO advances epigenetic cancer research with precise, reproducible inhibition of EZH2 and H3K27 trimethylation. This guide details protocol enhancements, troubleshooting, and cutting-edge workflows for robust results in malignant rhabdoid tumor and HPV-associated cervical cancer models.

• Circulating GPNMB Model Predicts Immunotherapy Response in E

  2026-08-03

  This study introduces a multimodal model leveraging circulating GPNMB and tumor microenvironment features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). By dissecting the mechanisms of GPNMB-driven CD8+ T cell exhaustion and integrating spatial and clinical data, the research provides a clinically actionable framework for precision immunotherapy stratification.

• Small Molecule-Enhanced Generation of Pancreatic Ductal Orga

  2026-08-03

  Liao et al. present a protocol using a small molecule cocktail to markedly improve the efficiency and stability of pancreatic ductal organoid (PDO) generation. This advance enables robust, long-term cultures that better model ductal cell diversity, supporting research in pancreatic disease biology and drug screening.

• Aconitase Activity Colorimetric Assay Kit: Precision in TCA

  2026-08-02

  Unlock rapid, high-sensitivity quantification of iron-sulfur protein aconitase activity with the Aconitase Activity Colorimetric Assay Kit. Designed for nuanced oxidative stress studies and immunometabolic workflows, this kit streamlines experimental throughput while delivering robust, reproducible results.

• BCECF-AM: Optimizing Intracellular pH Measurement Workflows

  2026-08-01

  BCECF-AM stands out as a ratiometric, cell-permeable dye enabling advanced intracellular pH measurement in mammalian and plant systems. This guide delivers actionable, protocol-driven insights and troubleshooting steps for extracting high-fidelity data from complex cell biology assays. Discover how APExBIO’s high-purity BCECF-AM can transform both routine and cutting-edge research.

• Targeted SPP1 Inhibition in Tumor-Associated Macrophages Red

  2026-07-31

  This study establishes that specific small-molecule inhibition of SPP1 in tumor-associated macrophages (TAMs) leads to significant tumor shrinkage in murine models. The research introduces a phenotypic screening approach to identify effective SPP1 modulators and demonstrates the therapeutic potential of a TAM-targeted nanoformulation.

• MLN4924 and Neddylation: Catalyzing Next-Gen Cancer Research

  2026-07-31

  This article provides translational researchers with a mechanistic and strategic roadmap for leveraging MLN4924—a potent NEDD8-activating enzyme (NAE) inhibitor—in cancer biology. Integrating recent insights into stress response signaling and the evolving role of the ubiquitin-proteasome system, it offers actionable guidance for experimental design, protocol optimization, and translational progression, while highlighting APExBIO's MLN4924 as a benchmark tool. The discussion bridges foundational biology with the latest findings on ribotoxic stress, situating MLN4924 at the intersection of cellular stress management and therapeutic innovation.

• Fenipentol (1-Phenyl-1-pentanol): Evidence, Mechanisms, and

  2026-07-30

  Fenipentol, also known as 1-Phenyl-1-pentanol, is a bioactive molecule with documented roles as a choleretic agent and modulator of gastrointestinal and hepatic physiology. Its verified mechanisms include estrogen receptor α interaction and robust effects on bile and pancreatobiliary secretions. This article consolidates current evidence, practical workflow parameters, and boundaries for research usage.

• Ajugol Enhances Mitophagy to Suppress Gouty Arthritis Pyropt

  2026-07-30

  The referenced study reveals that ajugol alleviates acute gouty arthritis by promoting mitophagy and suppressing chondrocyte pyroptosis through inhibition of the PI3K/AKT/mTOR pathway. These findings highlight a mitochondrial-targeted strategy for controlling inflammation and cartilage degeneration in gouty arthritis.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Pathway

  2026-07-29

  This study identifies gramine, a natural indole alkaloid, as a selective inhibitor of triple-negative breast cancer (TNBC) cell growth by inducing ferroptosis through the CUL3-mediated ubiquitination of MTDH. The work uncovers a novel regulatory axis for ferroptosis, offering new mechanistic insights and potential avenues for targeted therapy in TNBC.

16340 records 1/1090 page Next 12345 下5页 Last page